Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Health Service

Background Based on early evidence of a high rate of coronavirus mortality in patients with acute myeloid leukaemia (AML) undergoing intensive chemotherapy (IC), the national health service (NHS) in the United Kingdom temporarily made venetoclax available as an alternative therapy, with the aim of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Jad, Amer, Mariam, Amofa, Ruebina, Anderson, Laura, Austin, Michael J, Bashford, Alex, Belsham, Edward, Boot, Jesca, Campbell, Victoria Louise, Coats, Thomas, Collins, Angela, Crawley, Charles, Crolla, Francesca, Cross, Joe W, Dalley, Chris, Dang, Raymond, Dennis, Mike, Dhawan, Saniya, Elliott, Johnathon, Galli, Sofia, Gallipoli, Paolo, Hodgson, Katherine, Jain, Manish, Kalkur, Pallavi, Katsomitrou, Vana, Khan, Anjum, Khwaja, Asim, Krishnamurthy, Pramila, Latif, Annie, Laurie, John, Lim, Michael, Loizou, Eleana, Loke, Justin, Mannari, Deepak, Manson, Cara, Marshall, Scott R., Mobashwera, Behnaz, Murthy, Vidhya, Ochaya, Odong, Orthi, Shahzad, Palanicawandar, Renuka, Pillai, Srinivas, Radzova, Dominika, Rye, Adam, Saunders, Jamie, Smith, Matthew, Taussig, David, Taylor, Tom, Whitmill, Richard, Zhao, Rui, Freeman, Sylvie D, Craddock, Charles, Dillon, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
615.Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701549/
http://dx.doi.org/10.1182/blood-2021-149685

Ejemplares similares

Ejemplares similares